Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CHMA

Chiasma (CHMA) Stock Price, News & Analysis

Chiasma logo

About Chiasma Stock (NASDAQ:CHMA)

Advanced Chart

Key Stats

Today's Range
$3.76
$3.76
50-Day Range
$3.76
$4.71
52-Week Range
$2.77
$5.74
Volume
147 shs
Average Volume
2.12 million shs
Market Capitalization
$217.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CHMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chiasma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CHMA Stock News Headlines

Chiasma Craters on FDA Drug Rejection
Cover all your expenses with just $118,000 invested?
Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just discovered a new way to do it with 10X less money.tc pixel
MPM ASSET MANAGEMENT LLC Buys - GuruFocus.com
See More Headlines

CHMA Stock Analysis - Frequently Asked Questions

Chiasma, Inc. (NASDAQ:CHMA) issued its quarterly earnings data on Thursday, May, 6th. The biotechnology company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.31) by $0.18. The biotechnology company earned $1.92 million during the quarter, compared to the consensus estimate of $1.80 million.

Chiasma (CHMA) raised $76 million in an IPO on Thursday, July 16th 2015. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. Barclays and Cowen and Company acted as the underwriters for the IPO and William Blair and Oppenheimer & Co. were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chiasma investors own include Arbutus Biopharma (ABUS), Bausch Health Cos (BHC), Meta Platforms (META), GW Pharmaceuticals (GWPH), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
5/06/2021
Today
8/26/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CHMA
CIK
1339469
Fax
N/A
Employees
85
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
($1.43)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.78 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-113.57%
Return on Assets
-57.62%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.91
Quick Ratio
7.08

Sales & Book Value

Annual Sales
$1.11 million
Price / Sales
196.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.59 per share
Price / Book
2.36

Miscellaneous

Outstanding Shares
57,894,000
Free Float
N/A
Market Cap
$217.68 million
Optionable
Not Optionable
Beta
1.28

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CHMA) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners